Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers.
Shariat
Shahrokh F
SF
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. sfshariat@gmail.com
Youssef
Ramy F
RF
Gupta
Amit
A
Chade
Daher C
DC
Karakiewicz
Pierre I
PI
Isbarn
Hendrik
H
Jeldres
Claudio
C
Sagalowsky
Arthur I
AI
Ashfaq
Raheela
R
Lotan
Yair
Y
D019540:Area Under Curve; D014408:Biomarkers, Tumor / Q000378:metabolism*; D015653:Cystectomy; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D046228:Microarray Analysis; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D009389:Neovascularization, Pathologic / Q000378:metabolism*; D016016:Proportional Hazards Models; D016019:Survival Analysis; D019700:Thrombospondin 1 / Q000378:metabolism; D001749:Urinary Bladder Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
D014408:Biomarkers, Tumor; D019700:Thrombospondin 1; D042461:Vascular Endothelial Growth Factor A; D016222:Fibroblast Growth Factor 2